J. Matthews

发表

Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation

R. Harrup, D. Tuck, K. Marsden, 2001, Bone Marrow Transplantation.

Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir

J. Szer, J. Matthews, J. Sasadeusz, 2000, Bone Marrow Transplantation.

Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study

J. Szer, D. Roos, A. Wirth, 2005, Bone Marrow Transplantation.

The definition of refractoriness to platelet transfusions

J. Szer, K. Yuen, J. Matthews, 1992, Transfusion Medicine.

Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature

D. Allan, A. Tinmouth, C. Bredeson, 2016, Transfusion medicine.

A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma

B. Dale, J. Matthews, J. Biagi, 2005, Leukemia & lymphoma.

Laterality, maldescent, trauma and other clinical factors in the epidemiology of testis cancer in Victoria, Australia.

J. Matthews, D. Cruickshank, J. Stone, 1991, British Journal of Cancer.

Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma.

J. Matthews, D. Woodcock, M. Linsenmeyer, 1992, British Journal of Cancer.

Percentage increment measurements following platelet transfusions

J. Szer, K. Yuen, M. Wolf, 1993 .